1. US Food and Drug Administration. Approval letter for tisagenlecleucel BLA (2017). www.fda.gov/media/106989/download
2. Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme. Guide to good manufacturing practice for medicinal products. part I (2022). https://picscheme.org/docview/4588
3. Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme. Guide to good manufacturing practice for medicinal products, part II (2022). https://picscheme.org/docview/4589
4. Ministry of Health, Labour and Welfare. Ministry Ordinance on good gene, cellular, and tissue-based products manufacturing practice (Japan) (2014). https://elaws.e-gov.go.jp/document?lawid=426M60000100093_20210801_503M60000100015
5. European Commission. Guidelines on Good Distribution Practice of Medicinal Products for Human Use. 2013/C 343/01 (2013). https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2013:343:0001:0014:EN:PDF